Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07852871) titled 'miRNA to Guide Appropriate Intervention of Small Testis Masses' on Sept. 25.
Study Type: Observational
Primary Sponsor: University Health Network, Toronto
Condition:
Testis Cancer
Recruitment Status: Recruiting
Date of First Enrollment: July 12, 2023
Target Sample Size: 100
Countries of Recruitment:
Canada
To know more, visit https://clinicaltrials.gov/study/NCT07852871
Disclaimer: Curated by HT Syndication....